My first thought was man the prices sure have gone up A billion dollars a year for pot? Paul Armentano, The Examiner Oct 18, 2006 4:00 AM (9 hrs ago) WASHINGTON - American taxpayers are now spending more than a billion dollars per year to incarcerate its citizens for pot. That’s according to statistics released last week by the U.S. Department of Justice’s Bureau of Justice Statistics. According to the new BJS report, “Drug Use and Dependence, State and Federal Prisoners, 2004,” 12.7 percent of state inmates and 12.4 percent of federal inmates incarcerated for drug violations are serving time for mar1juana offenses. Combining these percentages with separate U.S. Department of Justice statistics on the total number of state and federal drug prisoners (BJS October 2005 Bulletin: “Prisoners in 2004” — NCJ 210677) suggests that there are now about 33,655 state inmates and 10,785 federal inmates behind bars for mar1juana offenses. (The report failed to include estimates on the percentage of inmates incarcerated in county jails for pot-related offenses.) Multiplying these totals by U.S. DOJ prison expenditure data (BJS June 2004 Bulletin: “State Prison Expenditures, 2001” — NCJ 202949) reveals that taxpayers are spending more than $1 billion annually to imprison pot offenders. The new report is noteworthy because it undermines the common claim from law enforcement officers and bureaucrats, specifically White House drug czar John Walters, that few, if any, Americans are incarcerated for mar1juana-related offenses. In reality, nearly 1 out of 8 U.S. drug prisoners are locked up for pot. Of course, several hundred thousand more Americans are arrested each year for violating mar1juana laws, costing taxpayers another $8 billion dollars annually in criminal justice costs. According to the most recent figures available from the FBI, police arrested an estimated 786,545 people on mar1juana charges in 2005 — more than twice the number of Americans arrested just 12 years ago. Among those arrested, about 88 percent — some 696,074 Americans — were charged with possession only. The remaining 90,471 individuals were charged with “sale/manufacture,” a category that includes all cultivation offenses, even those where the mar1juana was being grown for personal or medical use. These totals are the highest ever recorded by the FBI, and make up 42.6 percent of all drug arrests in the United States. Nevertheless, self-reported pot use by adults, as well as the ready availability of mar1juana on the black market, remains virtually unchanged. mar1juana isn’t a harmless substance, and those who argue for a change in the drug’s legal status do not claim it to be. However, pot’s relative risks to the user and society are arguably fewer than those of alcohol and tobacco, and they do not warrant the expenses associated with targeting, arresting and prosecuting hundreds of thousands of Americans every year. According to federal statistics, about 94 million Americans — that’s 40 percent of the U.S. population age 12 or older — self-identify as having used cannabis at some point in their lives, and relatively few acknowledge having suffered significant deleterious health effects due to their use. America’s public policies should reflect this reality, not deny it. It makes no sense to continue to treat nearly half of all Americans as criminals. Paul Armentano is the senior policy analyst for NORML and the NORML Foundation in Washington, DC.
Pot supporters really need to exploit this new finding, rather than worry about the typical issues. With all the baby-boomers getting up in age, this new finding is the easiest way to sway typical folks into legalizing it. http://www.webmd.com/content/article/101/106061.htm mar1juana Ingredient May Help Alzheimer's Chemical Counters Brain Problems in Alzheimer's Disease, Says Spanish Study By Miranda Hitti WebMD Medical News Reviewed By Brunilda Nazario, MD on Wednesday, February 23, 2005 Feb. 23, 2005 -- New clues about Alzheimer's disease have emerged from a Spanish study of mar1juana. The drug's active ingredients -- cannabinoids -- help prevent brain problems seen in Alzheimer's, say the scientists. There is no cure for Alzheimer's disease, which progressively damages brain areas involved in memory, judgment, language, and behavior. Alzheimer's disease is the most common form of mental decline, or dementia, in older adults. The new study didn't test cannabinoids on people living with Alzheimer's disease. Instead, the researchers focused on human brain tissue samples and conducted cannabinoid experiments on rats. The findings showed that "cannabinoids work both to prevent inflammation and to protect the brain," says researcher Maria de Ceballos in a news release. That "may set the stage for [cannabinoids'] use as a therapeutic approach for [Alzheimer's disease]." A staff member at Madrid's Cajal Institute, de Ceballos conducted the study with colleagues from nearby Complutense University. Their results appear in the Feb. 23 edition of The Journal of Neuroscience.
